Align Technology, Inc. vs Pfizer, Inc. — Stock Comparison
Align Technology, Inc. (ALGN) and Pfizer, Inc. (PFE) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Align Technology, Inc. narrowly edges Pfizer, Inc. on Q·Score (7 vs 6.4 out of 10), led by Growth (7.5 vs 5.1) and Sentiment (6.9 vs 5.3). Pfizer, Inc. scores higher on Quality, reflecting stronger profitability and returns. Analyst price targets imply similar upside for both: +14.8% for ALGN and +15.8% for PFE.
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Clean balance sheet with low leverage (0.0× debt-to-equity).
Forward P/E of 8.9× is low relative to sector peers.
⚠ earnings contracting 10% year-over-year.
Analyst Consensus
Fundamentals
Frequently Asked Questions
ALGN vs PFE: which stock scores better overall?
Based on Q·Score, Align Technology, Inc. (ALGN) scores 7/10 versus Pfizer, Inc. (PFE) at 6.4/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: ALGN or PFE?
Align Technology, Inc. (ALGN) scores higher on Growth (7.5/10 vs 5.1/10). Align Technology, Inc. reports revenue growth (6.2% YoY) while Pfizer, Inc. reports (5.4% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is ALGN or PFE more attractively valued?
Pfizer, Inc. (PFE) scores higher on Valuation (7.7/10 vs 7.3/10). ALGN trades at 14.7× P/E versus PFE at 8.9×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about ALGN vs PFE?
There are 14 analysts covering ALGN with a consensus price target of $209.07, and 27 analysts covering PFE with a consensus target of $29.19. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: ALGN or PFE?
Pfizer, Inc. (PFE) scores higher on Quality (6.4/10 vs 5.7/10). Net profit margin: ALGN at 10.5%, PFE at 11.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: ALGN or PFE?
Align Technology, Inc. (ALGN) scores higher on Financial Health (8/10 vs 7/10). Market beta: ALGN at 1.67, PFE at 0.29. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of ALGN and PFE?
Align Technology, Inc. (ALGN) has a market capitalisation of $13.0B, while Pfizer, Inc. (PFE) has a market cap of $143.7B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do ALGN or PFE pay dividends?
ALGN does not currently pay a dividend, while PFE pays a dividend yield of 6.61%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →